Business
SMAIO Obtains €2.0m in Non-Dilutive Financing
DALLAS & LYON, France, January 06, 2026--Regulatory News: SMAIO (Software, Machines and Adaptive Implants in Orthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker: ALSMA), a French-American player specialized in complex spine surgery, offering an integrated pre, intra, and post-operative solution based on a 3D planning software, adaptive implants and related services, today announced that it has obtained €2.0m in non-dilutive financing.
About this update from Bnp Paribas S.a. Class A
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":377,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/d8671a4e6dece37f148d467e5f15120c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Qz_j_gP3Cc_oCrx5GdypjA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTg5ODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/d8671a4e6dece37f148d467e5f15120c","width":377,"height":480}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"€1.0m in the form of a 0% interest loan co-financed by the European Union, the Auvergne-Rhône-Alpes Region and Bpifrance, with a repayment deferral period of two and a half years","length":178,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"€1.0m through loans from BNP Paribas and Société Générale","length":57,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":235,"olType":false},{"type":"text","content":"DALLAS & LYON, France, January 06, 2026--(BUSINESS WIRE)--Regulatory News:","length":78,"tagName":"p"},{"type":"text","content":"SMAIO (Software, Machines and Adaptive Implants in Orthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker: ALSMA), a French-American player specialized in complex spine surgery, offering an integrated pre, intra, and post-operative solution based on a 3D planning software, adaptive implants and related services, today announced that it has obtained €2.0m in non-dilutive financing.","length":394,"tagName":"p"},{"type":"text","content":"A €1.0m loan from the European Union, the Auvergne-Rhône-Alpes Region and Bpifrance","length":83,"tagName":"p"},{"type":"text","content":"Bpifrance, the European Union and the Auvergne-Rhône-Alpes Region have granted SMAIO a €1m loan at 0% interest, financed by the European Regional Development Fund (ERDF), with the aim of supporting its research and development (R&D) and commercial development. With a maturity of 7.5 years and a 2.5-year repayment deferral, this financing will enable SMAIO to continue investing in the development of innovative solutions and support their commercialization, particularly in the United States, the world's leading market for spine surgery.","length":548,"tagName":"p"},{"type":"text","content":"Two loans totaling €1.0m from its banking partners","lengt...